Zhang et al.
JOCArticle
24.4, 22.8, 22.4, 20.1, 14.0, 12.3; IR (neat, cm-1) 3078, 3057, 3031,
2954, 2925, 2857, 1637, 1602, 1574, 1495, 1443, 1377, 1246, 1112,
1070, 1018; MS (m/z) 337 (Mþ þ 1, 22.8), 336 (Mþ, 71.8), 293
(100); HRMS calcd for C24H32O 336.2448, found 336.2443.
(s, 1 H), 5.87-5.76 (m, 1 H), 5.03 (dq, J = 16.8 and 1.7 Hz, 1 H),
4.95 (dq, J = 10.0 and 1.6 Hz, 1 H), 3.12 (d, J = 5.6 Hz, 2 H),
2.33-2.25 (m, 4 H), 2.21 (s, 3 H), 2.14-2.09 (m, 2 H), 1.56-1.42
(m, 6 H), 1.39-1.26 (m, 4 H), 0.96 (t, J =7.2Hz, 6 H), 0.91 (t, J =
7.0 Hz, 3 H); 13C NMR (CDCl3, 100 MHz) δ 152.1, 145.0, 140.1,
137.1, 122.4, 120.0, 114.4, 109.6, 35.9, 35.25, 35.19, 31.5, 30.1,
24.8, 22.5, 22.4, 22.0, 14.5, 14.4, 14.1, 11.5; IR (neat, cm-1) 3077,
2958, 2928, 2870, 1637, 1466, 1377, 1210, 1132, 1078; MS (m/z)
303 (Mþ þ 1, 21.3), 302 (Mþ, 92.9), 273 (100); HRMS calcd for
C21H34O 302.2604, found 302.2604.
(11) 5-(1-Cyclohexylidenebut-3-en-1-yl)-2-methyl-3-pentyl-
furan (6hca). Following method B, the reaction of the first step
using CuI (1.5 mg, 0.008 mmol, 3 mol %), Pd(PPh3)2Cl2
(3.7 mg, 0.005 mmol, 2 mol %), 1h (66.8 mg, 0.25 mmol)/Et3N
(1 mL), and 2c (61.3 mg, 0.49 mmol, 2 equiv)/DMSO (1 mL)
afforded 3hc. The reaction of the second step using 3hc (from the
first step)/DMA (1 mL), 4a (122.1 mg, 1.0 mmol, 4.0 equiv)/
DMA (1 mL), and PdCl2 (1.9 mg, 0.01 mmol, 4 mol %) afforded
6hca (50.8 mg, 71%): liquid; 1H NMR (300 MHz, CDCl3) δ 5.94
(s, 1 H), 5.87-5.72 (m, 1 H), 5.01 (dq, J = 16.8 and 1.8 Hz, 1 H),
4.93 (dq, J = 10.2 and 1.7 Hz, 1 H), 3.11 (d, J = 6.0 Hz, 2 H),
2.50-2.41 (m, 2 H), 2.32-2.20 (m, 4 H), 2.19 (s, 3 H), 1.62-1.43
(m, 8 H), 1.38-1.22 (m, 4 H), 0.89 (t, J = 6.9 Hz, 3 H); 13C NMR
(CDCl3, 75 MHz) δ 151.9, 145.0, 140.1, 136.8, 119.9, 119.4, 114.3,
110.0, 35.3, 32.2, 31.5, 31.3, 30.1, 28.3, 28.2, 26.8, 24.8, 22.5, 14.1,
11.6; IR (neat, cm-1) 2926, 2854, 1637, 1552, 1448, 1377, 1216;
MS (m/z) 287 (Mþ þ 1, 21.4), 286 (Mþ, 100); HRMS calcd for
C20H30O 286.2291, found 286.2294.
(7)
2-Methyl-3-(methoxylpheyl)-5-(2-methylhexa-2,5-dien-
3-yl)-4-phenylfuran (6faa). Following method B, the reaction
of the first step using CuI (1.1 mg, 0.006 mmol, 2 mol %),
Pd(PPh3)2Cl2 (3.7 mg, 0.005 mmol, 2 mol %), 1f (95.8 mg, 0.25
mmol)/Et3N (1 mL), and 2a (41.7 mg, 0.50 mmol, 2 equiv)/
DMSO (1 mL) afforded 3fa. The reaction of the second step
using 3fa (from the first step)/DMA (1 mL), 4a (121.7 mg, 1.0
mmol, 4.0 equiv)/DMA (1 mL), and PdCl2 (1.7 mg, 0.01 mmol,
4 mol %) afforded 6faa (57.7 mg, 64%) (petroleum ether/ethyl
acetate = 100/1): liquid; 1H NMR (300 MHz, CDCl3) δ 7.21-
7.10 (m, 3 H), 7.04-6.97 (m, 4 H), 6.84-6.78 (m, 2 H), 5.88-5.74
(m, 1 H), 5.06-4.93 (m, 2 H), 3.79 (s, 3 H), 3.05 (d, J = 6.6 Hz,
2 H), 2.33 (s, 3 H), 1.74 (s, 3 H), 1.40 (s, 3 H); 13C NMR (CDCl3,
75 MHz) δ 157.9, 149.1, 146.6, 136.1, 135.4, 134.1, 130.8, 129.3,
127.8, 125.90, 125.87, 122.7, 122.3, 114.9, 113.4, 55.1, 36.6, 22.7,
20.3, 12.5; IR (neat, cm-1) 3034, 2919, 2854, 1636, 1603, 1574,
1511, 1444, 1374, 1329, 1287, 1245, 1175, 1107, 1072, 1042, 1021,
1006; MS (m/z) 359 (Mþ þ 1, 27.4), 358 (Mþ, 100); HRMS calcd
for C25H26O2 358.1933, found 358.1925.
(8) 3-Butyl-4-hexyl-2-methyl-5-(2-methylhexa-2,5-dien-3-yl)-
furan (6gaa). Following method B, the reaction of the first step
using CuI (1.1 mg, 0.005 mmol, 2 mol %), Pd(PPh3)2Cl2 (3.6 mg,
0.005 mmol, 2 mol %), 1g (84.3 mg, 0.25 mmol)/Et3N (1 mL),
and 2a (42.1 mg, 0.50 mmol, 2 equiv)/DMSO (1 mL) afforded
3ga. The reaction of the second step using 3ga (from the first
step)/DMA (1 mL), 4a (123.2 mg, 1.1 mmol, 4.2 equiv)/DMA
(1 mL), and PdCl2 (2.3 mg, 0.01 mmol, 5 mol %) afforded 6faa
(12) 5-(1,1-Diphenylpenta-1,4-dien-2-yl)-2-methyl-3-pentyl-
furan (6hda). Following method B, the reaction of the first step
using CuI (1.1 mg, 0.006 mmol, 2 mol %), Pd(PPh3)2Cl2 (3.7
mg, 0.005 mmol, 2 mol %), 1h (66.3 mg, 0.25 mmol)/Et3N
(1 mL), and 2d (103.6 mg, 0.50 mmol, 2 equiv)/DMSO (1 mL)
afforded 3hb. The reaction of the second step using 3hb (from
the first step)/DMA (1 mL), 4a (122.1 mg, 1.0 mmol, 4.0 equiv)/
DMA (1 mL), and PdCl2 (1.8 mg, 0.01 mmol, 4 mol %)
1
(60.1 mg, 76%): liquid; H NMR (300 MHz, CDCl3) δ 5.80-
5.65 (m, 1 H), 5.03-4.87 (m, 2 H), 3.04 (d, J = 6.6 Hz, 2 H), 2.28
(t, J = 7.7 Hz, 2 H), 2.20-2.12 (m, 5 H), 1.80 (s, 3 H), 1.65 (s,
3 H), 1.49-1.20 (m, 12 H), 0.96-0.84 (m, 6 H); 13C NMR
(CDCl3, 75 MHz) δ 147.7, 145.2, 136.3, 134.4, 123.4, 121.2,
119.3, 114.3, 36.9, 32.7, 31.7, 29.8, 29.6, 24.5, 23.7, 22.8, 22.6,
20.0, 14.1, 14.0, 11.8; IR (neat, cm-1) 2956, 2928, 2858, 2729,
1637, 1575, 1456, 1378, 1246, 1211, 1115; MS (m/z) 317 (Mþþ1,
19.9), 316 (Mþ, 85.7), 273 (100); HRMS calcd for C22H36O
316.2761, found 316.2767.
1
afforded 6hda (50.3 mg, 55%): liquid; H NMR (300 MHz,
CDCl3) δ 7.33-7.16 (m, 8 H), 7.13-7.08 (m, 2 H), 6.00-5.84
(m, 1 H), 5.52 (s, 1 H), 5.08-4.97 (m, 2 H), 3.23 (d, J = 6.0 Hz,
2 H), 2.14 (t, J = 7.2 Hz, 2 H), 2.02 (s, 3 H), 1.38-1.08 (m, 6 H),
0.86 (t, J = 7.1 Hz, 3 H); 13C NMR (CDCl3, 75 MHz) δ 151.0,
145.7, 144.0, 142.9, 138.7, 137.3, 129.6, 129.4, 127.94, 127.91,
126.9, 126.7, 126.4, 120.7, 115.3, 112.6, 36.4, 31.2, 29.8, 24.5, 22.5,
14.1, 11.4; IR (neat, cm-1) 3077, 3057, 3019, 2956, 2927, 2856,
1637, 1598, 1530, 1490, 1442, 1377, 1270, 1204, 1139, 1074, 1030;
MS (m/z) 371 (Mþ þ 1, 22.2), 370 (Mþ, 75.5), 329 ((Mþ - C3H5),
100); HRMS calcd for C27H30O: 370.2291, found 370.2283.
(13) 5-(2,2-Dimethylhexa-2,5-dien-3-yl)-2-methyl-3-pentyl-4-
phenylfuran (6aab). Following method B, the reaction of the
first step using CuI (1.0 mg, 0.005 mmol, 2 mol %), Pd(PPh3)2-
Cl2 (3.6 mg, 0.005 mmol, 2 mol %), 1a (86.5 mg, 0.25 mmol)/
Et3N (1 mL), and 2a (42.0 mg, 0.50 mmol, 2 equiv)/DMSO
(1 mL) afforded 3aa. The reaction of the second step using 3aa
(from the first step)/DMA (1 mL), 4b (132.0 mg, 1.0 mmol, 3.9
equiv)/DMA (1 mL), and PdCl2 (1.7 mg, 0.01 mmol, 4 mol %)
afforded 6aab (53.3 mg, 63%): liquid; 1H NMR (400 MHz,
CDCl3) δ 7.35-7.26 (m, 2 H), 7.25-7.16 (m, 3 H), 4.66 (s, 1 H),
4.60 (s, 1 H), 2.89 (s, 2 H), 2.31 (t, J = 7.5 Hz, 2 H), 2.25 (s, 3 H),
1.70 (s, 3 H), 1.62 (s, 3 H), 1.45 (s, 3 H), 1.38-1.08 (m, 6 H), 0.78
(t, J = 6.8 Hz, 3 H); 13C NMR (CDCl3, 100z) δ 148.6, 145.5,
143.8, 135.3, 135.1, 129.1, 128.0, 126.1, 123.6, 122.8, 119.2,
110.8, 40.0, 31.4, 29.8, 23.5, 22.8, 22.6, 22.3, 20.6, 14.0, 11.9;
IR (neat, cm-1) 3075, 3030, 2956, 2928, 2858, 1651, 1606, 1564,
1491, 1445, 1373, 1253, 1225, 1170, 1089, 1070, 1051, 1028; MS
(m/z) 337 (Mþ þ 1, 26.1), 336 (Mþ, 100); HRMS calcd for
C24H32O 336.2453, found 336.2456.
(9) 2-Methyl-5-(2-methylhexa-2,5-dien-3-yl)-3-pentylfuran (6haa).
Following method B, the reaction of the first step using CuI (1.4 mg,
0.007 mmol, 3 mol %), Pd(PPh3)2Cl2 (4.0 mg, 0.006 mmol,
2 mol %), 1h (67.7 mg, 0.25 mmol)/Et3N (1 mL), and 2a (45.3 mg,
0.54 mmol, 2 equiv)/DMSO (1 mL) afforded 3ha. The reaction of
the second step using 3ha (from the first step)/DMA (1 mL), 4a
(127.4 mg, 1.1 mmol, 4.2 equiv)/DMA (1 mL), and PdCl2 (2.4 mg,
1
0.014 mmol, 5 mol %) afforded 6haa (42.5 mg, 68%): liquid; H
NMR (300 MHz, CDCl3) δ 5.98 (s, 1 H), 5.88-5.73 (m, 1 H),
5.06-4.90 (m, 2 H), 3.13 (d, J = 6.0 Hz, 2 H), 2.28 (t, J = 7.7 Hz,
2 H), 2.19 (s, 3 H), 1.96 (s, 3 H), 1.82 (s, 3 H), 1.56-1.40 (m, 2 H),
1.39-1.20 (m, 4 H), 0.89 (t, J = 6.9 Hz, 3 H); 13C NMR (CDCl3,
75 MHz) δ 152.1, 144.9, 136.4, 130.7, 122.3, 120.1, 114.3, 110.1,
35.5, 31.5, 30.1, 24.8, 22.9, 22.5, 21.6, 14.1, 11.5; IR (neat, cm-1
)
2957, 2927, 2857, 1637, 1456, 1377, 1215, 1128, 1034; MS (m/z) 247
(Mþ þ 1, 19.1), 246 (Mþ, 100); HRMS calcd for C17H26O 246.1978,
found 246.1981.
(10) 2-Methyl-3-pentyl-5-(5-propylocta-1,4-dien-4-yl)furan
(6hba). Following method B, the reaction of the first step
using CuI (1.4 mg, 0.007 mmol, 3 mol %), Pd(PPh3)2Cl2
(3.6 mg, 0.005 mmol, 2 mol %), 1h (68.2 mg, 0.25 mmol)/Et3N
(1 mL), and 2b (71.2 mg, 0.51 mmol, 2 equiv)/DMSO (1 mL)
afforded 3hb. The reaction of the second step using 3hb (from
the first step)/DMA (1 mL), 4a (126.4 mg, 1.0 mmol,
4.2 equiv)/DMA (1 mL), and PdCl2 (2.1 mg, 0.012 mmol,
5 mol %) afforded 6hba (47.2 mg, 61%) (chromatography
twice on silica gel): liquid; 1H NMR (400 MHz, CDCl3) δ 5.99
(14) (E)-(2-Methyl-5-(penta-2,4-dien-2-yl)-3-pentyl-4-phenyl-
furan (7afa). Following method B, the reaction of the first step
J. Org. Chem. Vol. 75, No. 8, 2010 2597